Chocolate Syrup Market to Reach USD 12,631.37 Million by 2030, Growing at 4.0% CAGR: Polaris Market Research According to a new report by Polaris Market Research, the global chocolate syrup market was valued at USD 9,222.53 million in 2022 and is projected to reach USD 12,631.37 million by 2030, expanding at a CAGR of 4.0% over the forecast period (2022–2030). Growth is underpinned by...

The Cloud Managed Services Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period The Cloud Managed Services Market size was valued at US$ 112.01 Billion in 2025 and is projected to reach US$ 375.40 Billion by 2033, growing at a CAGR of 16.3% during 2026–2033.  Senior management should treat the market as a...

The Engineering Services Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Engineering Services Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to...

Polaris Market Research announces the release of its latest research report Medical Telepresence Robots Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve...

Polaris Market Research has published insightful research on Oil & Gas Analytics Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the study. The data in the...

Market Overview The pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is estimated at USD 9.61 billion in 2026. It is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% from 2026 to 2034. Pneumococcal vaccines are immunization products that protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and...